Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc (AMLN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Amylin Pharmaceuticals Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. The reporting company's CIK number is 881464.
Total stock buying since 2005: $166,931,228.
Total stock sales since 2005: $345,918,013.
Total stock option exercises since 2005: $11,112,250.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-07 | 0 | $0 | 0 | $0 | 56,300 | $672,785 |
| 2012-05 | 0 | $0 | 0 | $0 | 18,000 | $167,040 |
| 2012-03 | 0 | $0 | 20,616 | $405,007 | 5,000 | $45,100 |
| 2012-02 | 0 | $0 | 63,142 | $1,067,438 | 0 | $0 |
| 2012-01 | 0 | $0 | 1,832 | $21,232 | 5,993 | $0 |
| 2011-10 | 0 | $0 | 15,000 | $131,220 | 62,500 | $358,125 |
| 2011-05 | 0 | $0 | 0 | $0 | 3,000 | $33,090 |
| 2011-03 | 0 | $0 | 13,750 | $206,525 | 13,750 | $128,246 |
| 2011-02 | 0 | $0 | 12,500 | $202,035 | 12,500 | $139,060 |
| 2011-01 | 0 | $0 | 3,170 | $47,509 | 2,500 | $27,812 |
| 2010-11 | 0 | $0 | 1,314 | $17,633 | 25,000 | $278,125 |
| 2010-05 | 0 | $0 | 0 | $0 | 10,000 | $102,500 |
| 2010-04 | 0 | $0 | 0 | $0 | 638 | $8,453 |
| 2010-03 | 0 | $0 | 0 | $0 | 5,000 | $48,125 |
| 2010-02 | 0 | $0 | 0 | $0 | 72,606 | $1,036,886 |
| 2009-09 | 0 | $0 | 3,853,880 | $54,287,588 | 0 | $0 |
| 2009-02 | 0 | $0 | 0 | $0 | 16,344 | $12,764 |
| 2008-08 | 0 | $0 | 10,309,375 | $217,453,877 | 100 | $1,654 |
| 2008-06 | 261,207 | $7,815,313 | 0 | $0 | 0 | $0 |
| 2008-05 | 416,619 | $11,623,670 | 40,000 | $1,280,090 | 0 | $0 |
| 2008-04 | 4,502,240 | $131,997,310 | 60,000 | $1,925,620 | 0 | $0 |
| 2008-03 | 459,881 | $12,639,294 | 0 | $0 | 5,608 | $13,711 |
| 2008-02 | 75,000 | $2,014,300 | 8,308 | $254,047 | 76,724 | $326,259 |
| 2008-01 | 0 | $0 | 40,100 | $1,408,331 | 14,700 | $105,497 |
| 2007-12 | 0 | $0 | 41,100 | $1,551,648 | 22,700 | $148,395 |
| 2007-11 | 0 | $0 | 44,600 | $1,838,190 | 96,645 | $443,628 |
| 2007-10 | 0 | $0 | 51,800 | $2,510,251 | 20,700 | $214,490 |
| 2007-09 | 0 | $0 | 56,100 | $2,744,786 | 30,150 | $303,238 |
| 2007-08 | 0 | $0 | 109,914 | $5,427,298 | 73,700 | $858,126 |
| 2007-07 | 0 | $0 | 50,892 | $2,188,094 | 163,200 | $582,607 |
| 2007-06 | 0 | $0 | 53,892 | $2,406,633 | 39,098 | $486,521 |
| 2007-05 | 0 | $0 | 84,618 | $3,679,999 | 49,200 | $571,623 |
| 2007-04 | 0 | $0 | 54,738 | $2,196,776 | 20,700 | $118,979 |
| 2007-03 | 0 | $0 | 41,892 | $1,573,307 | 50,969 | $482,549 |
| 2007-02 | 0 | $0 | 27,892 | $1,107,171 | 16,700 | $140,907 |
| 2007-01 | 0 | $0 | 25,192 | $990,690 | 133,479 | $409,497 |
| 2006-12 | 0 | $0 | 32,692 | $1,254,682 | 29,673 | $354,844 |
| 2006-11 | 0 | $0 | 68,192 | $2,963,196 | 17,500 | $142,856 |
| 2006-10 | 0 | $0 | 62,038 | $2,752,057 | 17,500 | $163,626 |
| 2006-09 | 0 | $0 | 62,525 | $2,849,235 | 18,500 | $173,175 |
| 2006-08 | 0 | $0 | 79,038 | $3,498,594 | 21,593 | $175,972 |
| 2006-07 | 0 | $0 | 61,038 | $2,974,139 | 8,500 | $91,454 |
| 2006-06 | 0 | $0 | 30,846 | $1,417,078 | 18,869 | $286,120 |
| 2006-05 | 0 | $0 | 66,384 | $2,842,093 | 18,000 | $76,945 |
| 2006-04 | 0 | $0 | 59,692 | $2,758,785 | 23,000 | $121,569 |
| 2006-03 | 0 | $0 | 58,192 | $2,587,719 | 19,500 | $81,126 |
| 2006-02 | 0 | $0 | 97,846 | $3,951,179 | 54,154 | $72,276 |
| 2006-01 | 0 | $0 | 65,121 | $2,735,444 | 100,555 | $1,086,930 |
| 2005-12 | 0 | $0 | 39,940 | $1,543,914 | 3,500 | $19,565 |
| 2005-11 | 0 | $0 | 39,692 | $1,420,951 | 0 | $0 |
| 2005-10 | 0 | $0 | 34,692 | $1,215,665 | 0 | $0 |
| 2005-09 | 0 | $0 | 34,692 | $1,112,681 | 0 | $0 |
| 2005-08 | 0 | $0 | 13,538 | $317,177 | 0 | $0 |
| 2005-07 | 0 | $0 | 9,192 | $196,042 | 0 | $0 |
| 2005-06 | 0 | $0 | 31,692 | $604,387 | 0 | $0 |
| 2005-05 | 50,000 | $841,341 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-10-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 49.67 | 99,340 |
| 2007-10-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 2,000 | 16.54 | 33,080 |
| 2007-10-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 49.77 | 333,438 |
| 2007-10-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | 10.38 | 69,512 |
| 2007-10-01 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 49.67 | 49,670 |
| 2007-10-01 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2007-10-01 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 49.81 | 149,436 |
| 2007-10-01 | Baron Alain D (Sr VP Research) | Option Ex | 3,000 | 7.19 | 21,561 |
| 2007-10-01 | Greene Howard E Jr (Director) | Sale | 3,700 | 49.54 | 183,283 |
| 2007-09-28 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 3,000 | 49.98 | 149,931 |
| 2007-09-28 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 3,000 | 13.25 | 39,750 |
| 2007-09-26 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 50.00 | 250,000 |
| 2007-09-26 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 5.73 | 28,650 |
| 2007-09-18 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 47.75 | 47,750 |
| 2007-09-18 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2007-09-18 | Cook Joseph C Jr (Director) | Sale | 10,000 | 47.56 | 475,590 |
| 2007-09-17 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 48.74 | 243,710 |
| 2007-09-17 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 5.73 | 28,650 |
| 2007-09-17 | Greene Howard E Jr (Director) | Sale | 3,700 | 47.88 | 177,144 |
| 2007-09-05 | Graham Ginger L (Executive Advisor) | Option Ex | 1,450 | 19.77 | 28,666 |
| 2007-09-04 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 1,000 | 49.50 | 49,500 |
| 2007-09-04 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 1,000 | 16.80 | 16,800 |
| 2007-09-04 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 48.99 | 97,988 |
| 2007-09-04 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 2,000 | 20.73 | 41,450 |
| 2007-09-04 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 48.97 | 328,112 |
| 2007-09-04 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | 9.62 | 64,487 |
| 2007-09-04 | Eberhard Craig A (VP Sales) | Sale | 1,000 | 48.99 | 48,994 |
| 2007-09-04 | Eberhard Craig A (VP Sales) | Option Ex | 1,000 | 18.85 | 18,850 |
| 2007-09-04 | Baron Alain D (Sr VP Research) | Sale | 4,000 | 49.50 | 198,000 |
| 2007-09-04 | Baron Alain D (Sr VP Research) | Option Ex | 4,000 | 7.19 | 28,748 |
| 2007-09-04 | Cook Joseph C Jr (Director) | Sale | 10,000 | 49.49 | 494,910 |
| 2007-09-04 | Greene Howard E Jr (Director) | Sale | 3,700 | 49.50 | 183,157 |
| 2007-08-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 3,000 | 48.86 | 146,574 |
| 2007-08-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 3,000 | 13.25 | 39,750 |
| 2007-08-20 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 49.00 | 49,000 |
| 2007-08-20 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 11.12 | 11,125 |
| 2007-08-20 | Greene Howard E Jr (Director) | Sale | 3,700 | 48.92 | 180,992 |
| 2007-08-17 | Cook Joseph C Jr (Director) | Sale | 100 | 47.65 | 4,765 |
| 2007-08-16 | Cook Joseph C Jr (Director) | Sale | 9,900 | 48.26 | 477,803 |
| 2007-08-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 10,000 | 49.10 | 491,000 |
| 2007-08-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 10,000 | 14.28 | 142,810 |
| 2007-08-08 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 53.00 | 53,000 |
| 2007-08-08 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2007-08-08 | Wilson James N (Director) | Sale | 3,334 | 51.44 | 171,514 |
| 2007-08-08 | Graham Ginger L (Executive Advisor) | Sale | 23,000 | 51.33 | 1,180,659 |
| 2007-08-08 | Graham Ginger L (Executive Advisor) | Option Ex | 23,000 | 13.14 | 302,289 |
| 2007-08-07 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 50.00 | 25,000 |
| 2007-08-07 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-08-07 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 50.00 | 250,000 |
| 2007-08-07 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 14.28 | 71,405 |
| 2007-08-07 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 50.00 | 50,000 |
| 2007-08-07 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2007-08-07 | Wilson James N (Director) | Sale | 5,334 | 50.10 | 267,260 |
| 2007-08-07 | Graham Ginger L (Executive Advisor) | Sale | 10,000 | 50.51 | 505,100 |
| 2007-08-07 | Graham Ginger L (Executive Advisor) | Option Ex | 10,000 | 10.25 | 102,500 |
| 2007-08-06 | Graham Ginger L (Executive Advisor) | Sale | 10,000 | 49.50 | 495,010 |
| 2007-08-06 | Graham Ginger L (Executive Advisor) | Option Ex | 10,000 | 4.38 | 43,750 |
| 2007-08-06 | Greene Howard E Jr (Director) | Sale | 3,846 | 48.67 | 187,188 |
| 2007-08-02 | Cook Joseph C Jr (Director) | Sale | 100 | 46.63 | 4,663 |
| 2007-08-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 46.50 | 23,250 |
| 2007-08-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-08-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 46.31 | 92,622 |
| 2007-08-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-08-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 1,700 | 46.50 | 79,050 |
| 2007-08-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 1,700 | 9.62 | 16,362 |
| 2007-08-01 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.31 | 92,622 |
| 2007-08-01 | Eberhard Craig A (VP Sales) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-08-01 | Baron Alain D (Sr VP Research) | Sale | 3,000 | 46.50 | 139,500 |
| 2007-08-01 | Baron Alain D (Sr VP Research) | Option Ex | 3,000 | 7.19 | 21,561 |
| 2007-08-01 | Cook Joseph C Jr (Director) | Sale | 9,900 | 46.54 | 460,726 |
| 2007-07-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 3,500 | 47.43 | 166,019 |
| 2007-07-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 3,500 | 13.25 | 46,375 |
| 2007-07-27 | Cook Joseph C Jr (Director) | Option Ex | 140,000 | 2.66 | 371,840 |
| 2007-07-24 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 45.00 | 22,500 |
| 2007-07-24 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-07-24 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 45.50 | 91,000 |
| 2007-07-24 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 9.57 | 19,136 |
| 2007-07-23 | Greene Howard E Jr (Director) | Sale | 3,846 | 43.34 | 166,697 |
| 2007-07-18 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 43.18 | 43,180 |
| 2007-07-18 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 11.95 | 11,950 |
| 2007-07-17 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.96 | 429,610 |
| 2007-07-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 43.69 | 292,702 |
| 2007-07-16 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | 8.42 | 56,387 |
| 2007-07-12 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-07-12 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 7.19 | 14,374 |
| 2007-07-09 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.33 | 162,801 |
| 2007-07-03 | Cook Joseph C Jr (Director) | Sale | 10,000 | 41.92 | 419,180 |
| 2007-07-02 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 41.20 | 20,600 |
| 2007-07-02 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-07-02 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 41.00 | 82,000 |
| 2007-07-02 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-07-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.16 | 205,805 |
| 2007-07-02 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | 1.61 | 8,045 |
| 2007-06-29 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 41.38 | 103,455 |
| 2007-06-29 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 13.25 | 33,125 |
| 2007-06-25 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.34 | 158,989 |
| 2007-06-18 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 42.97 | 42,970 |
| 2007-06-18 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 9.62 | 9,625 |
| 2007-06-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 42.99 | 288,026 |
| 2007-06-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | 7.81 | 52,340 |
| 2007-06-12 | Graham Ginger L (Executive Advisor) | Option Ex | 2,898 | 23.00 | 66,654 |
| 2007-06-11 | Greene Howard E Jr (Director) | Sale | 3,846 | 41.46 | 159,470 |
| 2007-06-04 | Cook Joseph C Jr (Director) | Sale | 10,000 | 44.77 | 447,650 |
| 2007-06-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 1,000 | 46.16 | 46,160 |
| 2007-06-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 1,000 | 16.80 | 16,800 |
| 2007-06-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 2,000 | 46.64 | 93,280 |
| 2007-06-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-06-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 46.12 | 230,615 |
| 2007-06-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | .31 | 1,565 |
| 2007-06-01 | Eberhard Craig A (VP Sales) | Sale | 2,000 | 46.00 | 91,998 |
| 2007-06-01 | Eberhard Craig A (VP Sales) | Option Ex | 2,000 | 18.85 | 37,700 |
| 2007-06-01 | Baron Alain D (Sr VP Research) | Sale | 4,000 | 46.16 | 184,640 |
| 2007-06-01 | Baron Alain D (Sr VP Research) | Option Ex | 4,000 | 9.06 | 36,252 |
| 2007-06-01 | Testman Thomas R (Director) | Sale | 12,000 | 46.62 | 559,380 |
| 2007-06-01 | Testman Thomas R (Director) | Option Ex | 12,000 | 16.23 | 194,760 |
| 2007-05-31 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 6,500 | 45.79 | 297,661 |
| 2007-05-31 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 6,500 | 13.25 | 86,125 |
| 2007-05-31 | Wilson James N (Director) | Sale | 2,166 | 46.24 | 100,155 |
| 2007-05-30 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 46.00 | 46,000 |
| 2007-05-30 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 11.95 | 11,950 |
| 2007-05-29 | Greene Howard E Jr (Director) | Sale | 3,846 | 45.20 | 173,827 |
| 2007-05-25 | Testman Thomas R (Director) | Sale | 20,000 | 44.88 | 897,600 |
| 2007-05-25 | Testman Thomas R (Director) | Option Ex | 20,000 | 16.99 | 339,799 |
| 2007-05-22 | Wilson James N (Director) | Sale | 500 | 45.52 | 22,760 |
| 2007-05-21 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 45.00 | 22,500 |
| 2007-05-21 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-05-21 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 45.00 | 45,000 |
| 2007-05-21 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 10.94 | 10,940 |
| 2007-05-21 | Wilson James N (Director) | Sale | 2,166 | 44.80 | 97,036 |
| 2007-05-17 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.52 | 425,170 |
| 2007-05-16 | Baron Alain D (Sr VP Research) | Sale | 1,000 | 42.29 | 42,290 |
| 2007-05-16 | Baron Alain D (Sr VP Research) | Option Ex | 1,000 | 7.19 | 7,187 |
| 2007-05-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 6,700 | 42.29 | 283,329 |
| 2007-05-15 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 6,700 | 2.03 | 13,607 |
| 2007-05-14 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-05-14 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 11.95 | 23,900 |
| 2007-05-14 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.90 | 165,008 |
| 2007-05-07 | Bradbury Daniel (President & Chief Exec Officer) | Sale | 2,894 | 41.90 | 121,258 |
| 2007-05-02 | Cook Joseph C Jr (Director) | Sale | 10,000 | 42.07 | 420,700 |
| 2007-05-01 | Gergen Mark J (Sr VP, Corporate Development) | Sale | 500 | 41.25 | 20,625 |
| 2007-05-01 | Gergen Mark J (Sr VP, Corporate Development) | Option Ex | 500 | 16.80 | 8,400 |
| 2007-05-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Sale | 5,000 | 41.50 | 207,500 |
| 2007-05-01 | Rowland Lloyd A (VP, Gov/Compliance, Secretary) | Option Ex | 5,000 | 11.95 | 59,750 |
| 2007-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Sale | 5,000 | 41.12 | 205,580 |
| 2007-05-01 | Kolterman Orville G (Sr VP Clinical and Regulatory) | Option Ex | 5,000 | .31 | 1,565 |
| 2007-04-30 | Foletta Mark G (Senior VP, Finance & CFO) | Sale | 2,500 | 42.32 | 105,800 |
| 2007-04-30 | Foletta Mark G (Senior VP, Finance & CFO) | Option Ex | 2,500 | 13.25 | 33,125 |
| 2007-04-30 | Greene Howard E Jr (Director) | Sale | 3,846 | 42.09 | 161,889 |
| 2007-04-27 | Baron Alain D (Sr VP Research) | Sale | 2,000 | 43.00 | 86,000 |
| 2007-04-27 | Baron Alain D (Sr VP Research) | Option Ex | 2,000 | 11.95 | 23,900 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.